{
    "code": 0,
    "data": [
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Analyst call details attached",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc9f7668-ffe9-418f-a1ef-1a02a9400215.pdf",
            "news_date": "2026-02-11 21:40:10"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Intimation of acquisition of equity shares of J.B. Chemicals & Pharmaceuticals Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef1acbd5-0db9-4e75-afb9-cb8195bb0042.pdf",
            "news_date": "2026-02-03 22:02:53"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Intimation",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board to consider Dividend",
            "news_body": "Intimation of Record Date pursuant to Regulation 42 of SEBI Listing Regulations",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ac4e214-90ff-4826-ba1e-343e6bee0b50.pdf",
            "news_date": "2026-02-03 18:23:25"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Post Quarterly Financial Result Conference call with investors / analyst",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5755695-f032-4d5f-9bee-091f84505e79.pdf",
            "news_date": "2026-02-02 17:49:10"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Financial Results For Quarter Ended 31-Dec-25 And Interim Dividend For The Year 2025-26.",
            "news_body": "Torrent Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on 31-Dec-25. The Board would also consider payment of Interim Dividend for the year 2025-26.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79379a8d-586a-4d64-954a-9bc2985041b2.pdf",
            "news_date": "2026-02-02 09:45:57"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Change in Senior Management Personnel",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=274c68d1-687e-4688-8325-513698cc874f.pdf",
            "news_date": "2026-01-30 19:07:32"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)",
            "news_body": "Shifting of Registered Office",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a5d3706-f355-4400-976f-4d7b6092ff7f.pdf",
            "news_date": "2026-01-27 18:36:33"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Update on Acquisition",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1fdb2ee9-048f-474c-94e0-d88c0677d507.pdf",
            "news_date": "2026-01-23 18:41:45"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30",
            "news_body": "Intimation under Regulation 30",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55a727ce-643c-4899-a6fa-311bc73b4399.pdf",
            "news_date": "2026-01-23 17:23:31"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Intimation of acquisition of Equity Shares of J.B. Chemicals & Pharmaceuticals Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1dd987b-0f0f-4e6a-808a-fd6c2b279f57.pdf",
            "news_date": "2026-01-21 14:45:18"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of Equity Shares",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment",
            "news_body": "Intimation regarding allotment of Non Convertible Debentures",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83c82fcc-64c2-4592-9147-08d9bf37d8e0.pdf",
            "news_date": "2026-01-19 22:01:43"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of Equity Shares",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment",
            "news_body": "Intimation regarding Issue of Commercial Papers",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=745860ee-64f7-400d-a2df-2be76f27dc70.pdf",
            "news_date": "2026-01-19 20:56:27"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Intimation of Credit Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c443d2c5-cbaa-4c5d-9e71-7f3cf19632f8.pdf",
            "news_date": "2026-01-05 17:19:01"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Issue of Securities",
            "caption": "Announcement under Regulation 30 (LODR)-Issue of Securities",
            "news_body": "Issuance of Secured Rated Listed Redeemable Non Convertible Debentures (\"NCD)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=897c4361-9d52-4481-b255-54334d2af6ec.pdf",
            "news_date": "2026-01-05 11:09:18"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Issuance Of Secured Rated Listed Redeemable Non-Convertible Debentures (Ncds)",
            "news_body": "Issuance of Secured Rated Listed Redeemable Non-Convertible Debentures (NCDs)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c76cac61-3648-4044-8a8f-2f7ebeebd5ac.pdf",
            "news_date": "2026-01-05 11:05:01"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Credit rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=600ee9ca-851b-479f-bdfb-11323580b923.pdf",
            "news_date": "2026-01-02 22:05:17"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for To Consider And Approve The Proposal For\r\nIssuance Of Secured Non-Convertible Debentures On Private Placement Basis",
            "news_body": "Torrent Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/01/2026 inter alia to consider and approve to consider and approve the proposal for issuance of secured Non-Convertible Debentures on private placement basis within the limits approved by the Board of Directors of the Company at its meeting held on 28-Jul-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1cfe59a5-7890-4478-bd0e-285aebe7db25.pdf",
            "news_date": "2025-12-30 18:44:10"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of the closure of trading window as per companys code of conduct",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a29b8d5-32bc-481d-88f2-2cdfa36ffd0c.pdf",
            "news_date": "2025-12-26 16:41:57"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Redemption Of Commercial Papers Issued Under ISIN: INE685A14179",
            "news_body": "Redemption of Commercial Paper issued under ISIN: INE685A14179",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5dfdc137-7be8-4756-b0ca-05baafaa87d1.pdf",
            "news_date": "2025-12-23 17:59:53"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Redemption Of Commercial Papers Issued Under ISIN INE685A14161",
            "news_body": "Redemption of Commercial Papers issued under ISIN INE685A14161",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf5615ae-d85a-485c-a3bd-7f185b0fc373.pdf",
            "news_date": "2025-12-16 17:59:47"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Redemption Of Non-Convertible Debentures Issued Under ISIN: INE685A07082",
            "news_body": "Redemption of Non-convertible debenture issued under ISIN: INE685A07082",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=efcdc3f2-9d1c-4c81-b6dd-23eeb0d8898b.pdf",
            "news_date": "2025-12-12 15:54:13"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "NSE ESG Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d87299f9-dce6-46a2-ad56-4c583485ae8a.pdf",
            "news_date": "2025-12-10 15:07:13"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Intimation of acquisition of equity shares of J.B. Chemicals & Pharmaceuticals Limited under the Open Offer",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed5d0702-af1e-4c1c-acfb-77639606981e.pdf",
            "news_date": "2025-12-05 18:51:14"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper advertisement in respect of special window for re-lodgement of transfer requests of physical shares",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=397b7d55-81bc-464c-8df3-016a3f33d930.pdf",
            "news_date": "2025-11-28 18:02:32"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Disclosure under regulation 30 of SEBI (Listing Obligation and Disclosure Requirements",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5cd260b2-1ac1-4c32-ade1-4efe65b35a84.pdf",
            "news_date": "2025-11-28 13:37:35"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper advt in respect of the transfer of shares to IEPF",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f514f6a1-1ad5-49c9-a304-59f35d81ba40.pdf",
            "news_date": "2025-11-27 17:20:15"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Post Quarterly Financial Results conference call with investors / analyst",
            "news_id": "1e3da1f0-507b-486a-8546-7431d1e34972",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ebdc13cb-482b-4c38-83de-1b7f1e166d6a.pdf",
            "news_date": "2025-11-13 18:59:09",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Post Quarterly Financial Results conference call with investors / analyst",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ebdc13cb-482b-4c38-83de-1b7f1e166d6a.pdf",
            "news_date": "2025-11-13 18:59:09"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Audio Recording of Conference call with Analysts / Investors on Financial Results for the quarter and half year ended 30th September 2025",
            "news_id": "d80a2aae-a625-4b5a-913c-e2b9e3da0575",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2874803-e241-4563-a280-50b13858696c.pdf",
            "news_date": "2025-11-07 19:43:08",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Audio Recording of Conference call with Analysts / Investors on Financial Results for the quarter and half year ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2874803-e241-4563-a280-50b13858696c.pdf",
            "news_date": "2025-11-07 19:43:08"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Partial Redemption Of Commercial Papers Issued Under ISIN INE685A07124",
            "news_body": "Partial Redemption of Commercial Papers issued under ISIN INE685A07124",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99907c69-e8ff-4c3c-b01b-bb946a5055b0.pdf",
            "news_date": "2025-11-07 18:32:03"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on financial results Q2 FY 2025-26",
            "news_id": "607fdf1f-3e8b-46a6-8c5a-b56bb51f256d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e94e952-be35-4092-b775-7b3ece9ecce0.pdf",
            "news_date": "2025-11-07 17:52:33",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on financial results Q2 FY 2025-26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e94e952-be35-4092-b775-7b3ece9ecce0.pdf",
            "news_date": "2025-11-07 17:52:33"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated 07-Nov-25",
            "news_body": "Outcome of Board meeting dated 07-Nov-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1556420-2515-45ab-8f29-ec45aefc18aa.pdf",
            "news_date": "2025-11-07 17:48:52"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For Quarter And Half Year Ended 30-Sep-25",
            "news_body": "Results for quarter and half year ended 30-Sep-25",
            "news_id": "2bc3b0d0-df07-4dae-97ee-86c0da3249e2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=259a8ec4-5486-4fff-b996-c50cbb37b964.pdf",
            "news_date": "2025-11-07 17:45:39",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Results For Quarter And Half Year Ended 30-Sep-25",
            "news_body": "Results for quarter and half year ended 30-Sep-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=259a8ec4-5486-4fff-b996-c50cbb37b964.pdf",
            "news_date": "2025-11-07 17:45:39"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Post Quarterly Financial Result Conference call with investors / analyst",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aed5bda1-d46b-49d0-a1a8-2ba9ca83965b.pdf",
            "news_date": "2025-10-27 17:53:55"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Torrent Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 inter alia to consider and approve the Audited Financial Results on Standalone basis\r\nand Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on 30-Sep-25.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dff870e9-ebd5-4b43-b1cf-5abf82abf8b4.pdf",
            "news_date": "2025-10-27 16:40:36"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 20 Of SEBI LODR",
            "news_body": "Announcement under regulation 30 of SEBI LODR",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68b1d79c-af21-4262-8b43-8721da2148f2.pdf",
            "news_date": "2025-10-21 22:48:41"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Credit Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb6a9293-84bd-438c-9783-20bc6b3293bd.pdf",
            "news_date": "2025-10-07 16:17:16"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Credit Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=082ca754-b569-491b-b36b-ac792b97f573.pdf",
            "news_date": "2025-10-07 15:00:50"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015",
            "news_body": "Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=daddf964-40d2-4d49-8df5-b91f179f8ee4.pdf",
            "news_date": "2025-10-04 16:11:13"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper advertisement in respect of special window for re-lodgement of transfer request of physical shares",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=384bb12d-675d-4a6e-a02e-b2edd2a9eb84.pdf",
            "news_date": "2025-10-03 19:18:28"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Disclosure u/r 30 of SEBI(LODR) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b903109-4506-4e59-89a8-9c739aba1a2a.pdf",
            "news_date": "2025-09-30 18:59:22"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of the Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=984c03d9-9238-4021-972b-5079d42151b8.pdf",
            "news_date": "2025-09-29 17:27:52"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Redemption Of Commercial Papers Issued Under ISIN INE685A14153",
            "news_body": "Redemption of commercial papers issued under ISIN INE685A14153",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7cab620c-0407-40e1-b006-943a30129c7d.pdf",
            "news_date": "2025-09-26 19:08:43"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding Issue Of Commercial Papers",
            "news_body": "Intimation regarding issue of Commercial paper",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc62f277-86c8-424d-9391-10b8618303b4.pdf",
            "news_date": "2025-09-24 18:39:15"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Disclosure under Regulation 30 and other applicable provisions of SEBI LODR Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9c8651e-38a6-491d-a7aa-75431237e6a1.pdf",
            "news_date": "2025-09-23 20:43:41"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Redemption Of Commercial Papers Issued Under ISIN: INE685A14146",
            "news_body": "Redemption of Commercial papers issued under ISIN: INE685A14146",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ad87c86-e07a-460a-85c1-99062078d9b1.pdf",
            "news_date": "2025-09-18 16:03:26"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding Issue Of Commercial Papers",
            "news_body": "Intimation regarding issue of Commercial papers",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd4f73b8-06e4-41e1-baf2-e04398f18be1.pdf",
            "news_date": "2025-09-17 19:47:31"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Acquisition",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5593936-27bd-4d03-9764-1b35f39de1ba.pdf",
            "news_date": "2025-09-10 16:17:02"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement - 100 days IEPFA campaign",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a42643ed-38da-4614-a83d-8f2ee8f1c93b.pdf",
            "news_date": "2025-09-09 18:01:37"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper advertisement in respect of special window for re-lodgement of transfer requests of physical shares",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=300b6e0c-d8b8-47f5-8a42-dfed0d8fd86c.pdf",
            "news_date": "2025-08-05 17:55:34"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Reg 30",
            "news_body": "Announcement under reg 30",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59a3e708-4c4c-4f81-9485-d1432ad6bf44.pdf",
            "news_date": "2025-08-02 13:01:51"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of conference call",
            "news_id": "c025f1b4-854a-4323-92be-141d67ec055d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c68ae7d-da12-4018-b0d7-901d89a709ad.pdf",
            "news_date": "2025-07-31 19:19:47",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of conference call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c68ae7d-da12-4018-b0d7-901d89a709ad.pdf",
            "news_date": "2025-07-31 19:19:47"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Declaration of Voting result and scrutinizer report",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1e3a454-5b8f-41b3-8ee2-81bda5f35ae9.pdf",
            "news_date": "2025-07-29 16:04:26"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June 2025",
            "news_id": "76083aaf-550c-427e-a200-2aff53534779",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce2a2380-22dc-4cfd-a707-f7eec3b15cfd.pdf",
            "news_date": "2025-07-28 19:39:27",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce2a2380-22dc-4cfd-a707-f7eec3b15cfd.pdf",
            "news_date": "2025-07-28 19:39:27"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Managing Director of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=005e2ccf-e5bc-4298-904b-a7eb778f5959.pdf",
            "news_date": "2025-07-28 17:17:22"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Change in Senior Management Personnel",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8ef7ebf-1bef-43ec-8224-fb95ede57dc1.pdf",
            "news_date": "2025-07-28 17:07:52"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Secretarial Auditors",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5cf4184a-ea00-4566-914b-f1a1b47e92e0.pdf",
            "news_date": "2025-07-28 16:56:10"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Proceedings of 52nd AGM held on 28-jul-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f678afb8-2bf8-41d8-9a15-21910368be8b.pdf",
            "news_date": "2025-07-28 16:47:33"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation to analysts on unaudited Consolidated Financial Results for the quarter ended 30-Jun-25",
            "news_id": "401c126c-8d77-412f-93c0-e28bfe9dc64a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f40893d7-5b78-43c0-b37c-50d1a127a763.pdf",
            "news_date": "2025-07-28 16:13:13",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation to analysts on unaudited Consolidated Financial Results for the quarter ended 30-Jun-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f40893d7-5b78-43c0-b37c-50d1a127a763.pdf",
            "news_date": "2025-07-28 16:13:13"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated 28-Jul-25",
            "news_body": "Outcome of Board Meeting dated 28-Jul-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=944c4de4-7539-48ac-8fb4-d669411013e3.pdf",
            "news_date": "2025-07-28 16:08:31"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For Quarter Ended 30-Jun-25",
            "news_body": "Results for quarter ended 30-Jun-25",
            "news_id": "d8f91692-93f8-4f90-aed8-74ac987aaf16",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3499cf77-9c07-48a2-90f7-79c0f6a48c47.pdf",
            "news_date": "2025-07-28 16:04:17",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Results For Quarter Ended 30-Jun-25",
            "news_body": "Results for quarter ended 30-Jun-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3499cf77-9c07-48a2-90f7-79c0f6a48c47.pdf",
            "news_date": "2025-07-28 16:04:17"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Post Quarterly Financial Result Conference call with investors / analyst We hereby inform that the Company has scheduled a teleconference with Investors / Analyst on 28th July 2025 at 06:30 P.M. to discuss the financial performance of the Company for the quarter ended 30th June 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68c7f6cf-e542-44aa-bf81-2b5c0d6bbffd.pdf",
            "news_date": "2025-07-21 21:51:15"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Torrent Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2025 inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results with limited review on Consolidated basis of the Company for the quarter ended on 30-Jun-25. \r\n\r\nIn the above meeting the Board would also consider the Issue of Unsecured or Secured Redeemable Non Convertible Debentures or Bonds by way of private placement.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=243d927c-b942-43f7-bb3c-8700b80f820a.pdf",
            "news_date": "2025-07-21 19:04:59"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations) Letter To Shareholders - Integrated Annual Report FY 2024-25",
            "news_body": "Letter to shareholders - Integrated Annual Report FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef8a0c31-bbc6-4baf-81e9-210d47cb9801.pdf",
            "news_date": "2025-07-07 20:39:31"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement in respect of AGM and E-voting procedure",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d67e9f1-a514-42f6-9c39-6dd2ce5a8ad0.pdf",
            "news_date": "2025-07-05 16:51:22"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Submission of Business Responsibility and Sustainability Report for the FY 2024-25 of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5e846a9-9190-4494-a112-590cf018c735.pdf",
            "news_date": "2025-07-04 17:53:19"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Submission of Annual Report for FY 2024-25 and intimation of voting through electronic means",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72f4c6a4-acaf-4542-9ee0-563a58f66ed3.pdf",
            "news_date": "2025-07-04 17:47:28"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Disclosure under Regulation 30 and other applicable provisions of SEBI Listing Regulations",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa497e2b-dfd1-4367-bf4f-d2e319e9c295.pdf",
            "news_date": "2025-07-03 21:03:18"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement - Intimation of the 52nd AGM of the Company through VC / OAVM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=593d5b60-4ad4-4991-b177-0f6e6d60f7d8.pdf",
            "news_date": "2025-07-01 17:21:39"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "60cab576-d031-4f53-ad71-60c8347d5d35",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6314da61-f7f2-42a3-a461-607c3a8f44ad.pdf",
            "news_date": "2025-06-30 13:18:36",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6314da61-f7f2-42a3-a461-607c3a8f44ad.pdf",
            "news_date": "2025-06-30 13:18:36"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Closure of Trading Window as per Companys Code of Conduct to Regulate Monitor and Report Trading by Designated Persons",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53bef4ae-ba63-4c21-b03c-c440f049a1db.pdf",
            "news_date": "2025-06-30 12:31:15"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Conference call with investors / analyst",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ceccba5a-075d-46f1-819b-9fdc4f82e347.pdf",
            "news_date": "2025-06-30 09:30:33"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Announcement under regulation 30 (LODR) -  Acquisition",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef0465fd-6991-423c-ab54-ed929444c992.pdf",
            "news_date": "2025-06-29 19:59:11"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Disclosure Pursuant To Regulation 30 Read With Schedule III And Regulation 51 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (Listing Regulations).",
            "news_body": "Disclosure pursuant to Regulation 30 read with Schedule III and Regulation 51 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended (Listing Regulations)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=812e57e4-43fe-4f97-86e4-d04648a977a2.pdf",
            "news_date": "2025-06-29 19:45:56"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Redemption Of Commercial Paper Issued Under ISIN INE685A14120",
            "news_body": "Redemption of Commercial Paper Issued under ISIN INE685A14120",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bdea8a4d-7de3-4241-9a8c-af9f7392cd8c.pdf",
            "news_date": "2025-06-27 19:21:22"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding Issue Of Commercial Papers",
            "news_body": "Intimation regarding issue of commercial papers",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3a95ce8-b943-4367-90b3-61d469450c0e.pdf",
            "news_date": "2025-06-26 19:54:05"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Redemption Of Commercial Paper Issued Under ISIN INE685A14138",
            "news_body": "Redemption of Commercial Papers under ISIN INE685A14138",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18e2e5df-6788-43f1-9d39-c1218a9fb137.pdf",
            "news_date": "2025-06-23 16:04:54"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Issue of Securities",
            "caption": "Announcement under Regulation 30 (LODR)-Issue of Securities",
            "news_body": "Issuance of Commercial Papers",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3773b86-0d15-4098-aa85-323ca6000541.pdf",
            "news_date": "2025-06-20 20:35:56"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "ESG Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=652960cf-48b7-497a-ac51-a9e420405626.pdf",
            "news_date": "2025-06-09 20:05:34"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication with respect to IEPF",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=084220de-d5b1-4d3c-968f-01d7d781bb6d.pdf",
            "news_date": "2025-05-29 19:16:28"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call",
            "news_id": "2923b3a9-4a7e-49fc-80f8-f45d905aaf27",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb1d6559-1989-41bc-94c7-564eddae7ee8.pdf",
            "news_date": "2025-05-23 22:34:35",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb1d6559-1989-41bc-94c7-564eddae7ee8.pdf",
            "news_date": "2025-05-23 22:34:35"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Annual Secretarial Compliance Report for the year ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee2b4012-ef7e-401a-9a28-6eed4aeb100d.pdf",
            "news_date": "2025-05-21 14:56:05"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference call with Analysts / Investors on Audited Financial Results for the quarter and year ended 31st March 2025",
            "news_id": "42ffc965-a931-4bb4-917d-e3defaada4de",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e31fd468-d11f-4370-835d-1a6eaea5755d.pdf",
            "news_date": "2025-05-20 19:46:35",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference call with Analysts / Investors on Audited Financial Results for the quarter and year ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e31fd468-d11f-4370-835d-1a6eaea5755d.pdf",
            "news_date": "2025-05-20 19:46:35"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Code of Conduct under SEBI (PIT) Regulations 2015",
            "caption": "Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015",
            "news_body": "Revised code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c684fea5-1232-4a4e-90b1-a88d9849d79b.pdf",
            "news_date": "2025-05-20 19:05:52"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Change in Directorate",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97353347-d336-4d03-b146-07cc6305529b.pdf",
            "news_date": "2025-05-20 17:46:23"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Intimation Of Record Date For The Purpose Of Payment Of Final Dividend For FY 2024-25",
            "news_body": "Intimation of record date for the purpose of payment of final dividend for FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da291954-c7e6-42ba-a2a8-fb9ffcabec3a.pdf",
            "news_date": "2025-05-20 17:45:22"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Raising of Funds",
            "caption": "Announcement under Regulation 30 (LODR)-Raising of Funds",
            "news_body": "Raising of funds",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42e116ce-7fbe-4206-8b9c-1bd95357bc9d.pdf",
            "news_date": "2025-05-20 17:42:35"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Dividend Updates",
            "caption": "Announcement under Regulation 30 (LODR)-Dividend Updates",
            "news_body": "Dividend updated",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4680967b-2575-4ba9-94f2-b52dc29cca96.pdf",
            "news_date": "2025-05-20 17:40:21"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Date of payment of Dividend",
            "caption": "Announcement under Regulation 30 (LODR)-Date of payment of Dividend",
            "news_body": "Date of payment of Final Dividend 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f27bf03-06db-4f3f-9752-5f38b8ecd7ab.pdf",
            "news_date": "2025-05-20 17:38:55"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Outcome",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "Dividend Update",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ed419e6-d030-40a1-9ff6-c870e58db98f.pdf",
            "news_date": "2025-05-20 17:35:34"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Secretarial Auditor",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1f37e575-17d0-4f72-920b-7d346be908a8.pdf",
            "news_date": "2025-05-20 17:32:36"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated 20-May-25",
            "news_body": "Outcome of Board meeting dated 20-May-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c8dd597-08a5-4c5f-b260-dce205c16029.pdf",
            "news_date": "2025-05-20 17:29:07"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "d91ac46c-3826-45f6-8ddb-1ddfec6e79a7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09f70655-a2f4-4b63-8191-9e0d2855cbce.pdf",
            "news_date": "2025-05-20 17:24:03",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09f70655-a2f4-4b63-8191-9e0d2855cbce.pdf",
            "news_date": "2025-05-20 17:24:03"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results Q4 And Year Ended 31-03-2025.",
            "news_body": "Results",
            "news_id": "ce2b4733-b298-450b-b46b-136ca365fb8c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6bd444ce-1a01-4b87-bc05-ba0818d8ba67.pdf",
            "news_date": "2025-05-20 17:19:48",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Results Q4 And Year Ended 31-03-2025.",
            "news_body": "Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6bd444ce-1a01-4b87-bc05-ba0818d8ba67.pdf",
            "news_date": "2025-05-20 17:19:48"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results Q4 And Year Ended 31-03-2025.",
            "news_body": "Results",
            "news_id": "a1f6208f-fa5c-4896-bf35-bf64c7758736",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fee6381-8bc2-4f61-a825-ebdef58b7439.pdf",
            "news_date": "2025-05-20 17:18:36",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Results Q4 And Year Ended 31-03-2025.",
            "news_body": "Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fee6381-8bc2-4f61-a825-ebdef58b7439.pdf",
            "news_date": "2025-05-20 17:18:36"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Post Quarterly Financial Result Conference call with investors / analyst",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1500aa0-049f-4d05-a6b7-5ed5ac635274.pdf",
            "news_date": "2025-05-13 19:47:49"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for To Consider And Approve The Audited Financial Results Of The Company For The Year Ended On 31-Mar-25",
            "news_body": "Torrent Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 inter alia to consider and approve the Audited Financial Results of the Company for the year ended on 31-Mar-25; Recommendation of final dividend; Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through QIP and / or Depository Receipts or any other modes.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f09aa810-9027-426f-949a-f94e578f910e.pdf",
            "news_date": "2025-05-13 19:42:23"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Cessation",
            "caption": "Announcement under Regulation 30 (LODR)-Cessation",
            "news_body": "Intimation of cessation of Director of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5818c00d-287f-4cad-8f6c-9674c2ead662.pdf",
            "news_date": "2025-05-11 13:22:08"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of the Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c5886a1-931a-403a-b231-7ed765ffb549.pdf",
            "news_date": "2025-03-28 11:25:44"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "Issue of Securities",
            "caption": "Announcement under Regulation 30 (LODR)-Issue of Securities",
            "news_body": "Intimation regarding Issue of Commercial Papers",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ae9c068-4218-46be-bac7-0c4b6ba31983.pdf",
            "news_date": "2025-03-26 19:49:40"
        },
        {
            "co_code": 3616,
            "bse_code": 500420,
            "isin": "INE685A01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Redemption Of Commercial Paper Issued Under ISIN INE685A14112",
            "news_body": "Redemption of Commercial paper issued under ISIN iINE685A14112",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=408dacd7-ed30-4fbe-a835-7790853f41c0.pdf",
            "news_date": "2025-03-26 19:12:14"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of conference call with Analysts / Investors on Financial Results for the quarter and nine months ended 31st December 2024",
            "news_id": "dabbc168-3058-448d-b0eb-a01252ad5b34",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fcab31f7-0c14-4010-87d9-26f9c7e6497d.pdf",
            "news_date": "2025-01-31 12:21:52",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Financial Results Q3 FY 2024-25.",
            "news_id": "897992a1-f4ec-4c2d-bccd-3738cadf755e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=645825e0-582d-4814-9a5a-801fc99b4425.pdf",
            "news_date": "2025-01-24 17:03:28",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results Q3 FY 2024-25.",
            "news_body": "Results Q3 FY 2024-25",
            "news_id": "13d70500-f8b6-4569-a213-792860c2aa97",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a199b25-0d02-4052-962c-07d2b7253658.pdf",
            "news_date": "2025-01-24 16:45:35",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earning Call Transcript",
            "news_id": "73cb0afc-28a3-4a7e-8b45-38a6c704f94f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=361f13b1-b2a6-421c-a368-19b26e108150.pdf",
            "news_date": "2024-10-30 17:25:11",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference call with Analysts / Investors on Financial Results for the quarter and half year ended 30th September, 2024.",
            "news_id": "c44ede70-0806-4274-90db-99392b2984b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1405eb60-bba8-46f9-9018-8b33b6ff6021.pdf",
            "news_date": "2024-10-25 19:17:05",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Financial Results Q2 FY 2024-25.",
            "news_id": "23c9433c-67ab-4ac4-ba9b-71542d90b1d0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f39a280c-aac0-4ed9-bb13-d91f8fe6c9df.pdf",
            "news_date": "2024-10-25 17:29:17",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results Q2 FY 2024-25",
            "news_body": "Results Q2 FY 2024-25.",
            "news_id": "fec52751-7376-4026-8812-4be0ad58a01d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=670cce05-2558-40a7-8be0-98247cddf8b4.pdf",
            "news_date": "2024-10-25 17:18:18",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June, 2024",
            "news_id": "4b614904-87f1-4fcb-ad1b-c79ab356fa39",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=222507ea-9b52-4e0d-80a7-83707abd39d9.pdf",
            "news_date": "2024-07-29 16:15:13",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June, 2024",
            "news_id": "a3f4e854-f998-4ac0-8c7e-9a333daaf39f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31ba1732-b394-4b51-85b5-676dffcb5ef2.pdf",
            "news_date": "2024-07-23 20:39:52",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation.",
            "news_id": "68c26b63-c478-458b-b41e-d5f6b008e3db",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa02d9f7-5285-4cc8-83e4-d7e079c4d054.pdf",
            "news_date": "2024-07-23 17:29:47",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results",
            "news_body": "Results Q1 FY 2024-25.",
            "news_id": "8d4bf8bc-8d29-4df9-ae24-f6b045535d18",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f88c25d5-ebec-45d3-b778-c4be3d9b4ab4.pdf",
            "news_date": "2024-07-23 17:20:51",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call with Analysts / Investors on Audited Financial Results for the quarter and year ended 31st March, 2024",
            "news_id": "ec003492-2c1a-46c5-8c2c-25dffe132fd4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e64c694c-2f62-47e1-8af0-9e16ffe40f50.pdf",
            "news_date": "2024-05-30 12:54:03",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "In continuation to our letter dated 10-May-24 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference call with Analysts / Investors on Audited Financial Results of the Company for the quarter and year ended 31st March, 2024, has been placed on the Company's website at https://www.torrentpharma.com/pdf/investors/Audio_Recording31032024.mp3",
            "news_id": "edc4c3c7-90af-4ec2-a09e-d20979434e2a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9dece7aa-80ad-4bb4-a212-ce50e19c54b0.pdf",
            "news_date": "2024-05-24 20:14:45",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation",
            "news_id": "dcacd2ee-e37f-4e30-957a-8da42b5416e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a717b30c-f348-44c7-9f3a-cad05e04b26a.pdf",
            "news_date": "2024-05-24 17:54:04",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results",
            "news_body": "Results",
            "news_id": "53d0af19-a5d8-40d7-a36a-2994b6984841",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3054957f-ff78-4bf3-9d1d-7b9126367fde.pdf",
            "news_date": "2024-05-24 17:48:28",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call with Analysts / Investor on Financial Results for the quarter and nine months ended 31st December, 2023",
            "news_id": "5bdc7bfc-83a0-40fb-906c-592a1523f59d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7762fe1b-da9d-435a-8b80-f6286b6c31a9.pdf",
            "news_date": "2024-02-07 12:20:27",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Con-Call With Analyst / Investor On Financial Result For Quarter And Nine Months Ended 31.12.2023",
            "news_body": "Audio recording",
            "news_id": "adf9e939-f5cb-4fa5-a6c6-12155b08cc77",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92ebffe4-7736-4517-8758-ab139c75c1fb.pdf",
            "news_date": "2024-02-02 18:17:35",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation",
            "news_id": "4738c8c9-3f84-45e6-b3dd-2eeb1dffe1e1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1cf60f33-090d-4f23-9a53-429f7217bbd0.pdf",
            "news_date": "2024-02-02 14:04:20",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Result - Q3 2023-24",
            "news_body": "Result",
            "news_id": "792f58e7-bcf4-4cb7-9944-30c1ae432ead",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=900f497f-1ac0-4ab2-8551-31279d7c502a.pdf",
            "news_date": "2024-02-02 13:53:23",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of conference call with Analysts / Investors on Financial Results for the quarter and half year ended 30th September, 2023",
            "news_id": "e2c257ee-1b3d-42fb-83a9-e17b5658c8f5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27188d3a-20e5-42ba-a9fb-7bdc4a234de0.pdf",
            "news_date": "2023-10-26 09:53:28",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation",
            "news_id": "28329a4f-1e92-4a41-95cc-1f548d26d05e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9e74868-f4c2-46f0-8357-29eec8f647b6.pdf",
            "news_date": "2023-10-23 18:02:21",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter And Half Year Ended 30-Sep-23",
            "news_body": "Financial results for quarter and half year ended 30-sep-23",
            "news_id": "bfad3ad7-e067-45ac-8f65-0b5870d73520",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d215bae-7c86-433c-8ddc-7feec8aa1624.pdf",
            "news_date": "2023-10-23 17:49:35",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference call with Analysts / investors on financial results for the quarter ended 30th June, 2023 attached.",
            "news_id": "0cf11c12-42a7-4332-b8cd-cfca0d7139bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e064d44-b544-4898-86f7-136da0da704c.pdf",
            "news_date": "2023-08-11 17:41:54",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Conference Call With Analysts / Investors On Financial Results For The Quarter Ended 30Th June, 2023",
            "news_body": "Audio Recording of Conference call with Analysts /Investors on Financial Results for the quarter ended 30th June, 2023 is attached",
            "news_id": "773ad838-e5fa-4fb6-bf1c-5de89944864d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf516e89-0edc-48e7-88a8-f3e191b8fb62.pdf",
            "news_date": "2023-08-07 20:26:43",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation to analyst on unaudited consolidated financial result for quarter ended 30.06.2023",
            "news_id": "40fab8e3-1775-4863-94b8-7686f7d3364b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ea28e7d-ae7a-4f44-a2d3-d4cb39c25a42.pdf",
            "news_date": "2023-08-07 16:59:51",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission / Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations') - Financial Results For Quarter Ended 30Th June, 2023",
            "news_body": "Submission / Intimation u/r 30 of SEBI (LODR) Regulation, 2015 - Financial Result for quarter ended 30th June, 2023",
            "news_id": "7949d4c6-5f47-491d-b957-384a54bee14d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72481cdb-868b-45c8-a3b6-d981cc897fd4.pdf",
            "news_date": "2023-08-07 16:40:48",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In continuation of our letter dated 16-May-23 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Transcript of Conference call with Analysts / Investors on Audited Financial Results of the Company for the quarter and year ended 31st March, 2023, has been placed on the Company's website at https://www.torrentpharma.com/pdf/investors/Earnings_Call_Transcript_May_30_2023.pdf",
            "news_id": "f9166b7d-eb98-43e5-9b93-3bb0ec37c13d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a036f42-3871-4953-819e-be809aeecaa2.pdf",
            "news_date": "2023-06-03 13:48:28",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Conference Call With Analysts / Investors On Audited Financial Results For The Quarter And Year Ended 31St March, 2023",
            "news_body": "In continuation to our letter dated 16-May-23 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference call with Analysts / Investors on Audited Financial Results of the Company for the quarter and year ended 31st March, 2023, has been placed on the Company's website at https://www.torrentpharma.com/pdf/investors/Audio_Recording31032023.mp3",
            "news_id": "cb76a353-c3a2-4b7b-aa33-9a9237ab43c1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63b36ae7-02fb-4c88-87e9-50a4cd333339.pdf",
            "news_date": "2023-05-30 19:58:37",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation to analysts on Audited Financial Results for the quarter and year ended 31st March, 2023",
            "news_id": "1a4f5883-250e-4b2b-b4f6-1225b4871385",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c993e1f5-4975-444a-92b4-507ae1bb2fe6.pdf",
            "news_date": "2023-05-30 17:49:34",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Pursuant To Regulation 30 Read With Schedule III And Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements), 2015, (Listing Regulations)",
            "news_body": "Disclosure pursuant to Regulation 30 read with Schedule III and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015, (Listing Regulations)",
            "news_id": "2b7ae93a-33da-4b72-b33b-b97a0d5c1d96",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b730e3f-9b43-4213-bc19-7e7e827fd605.pdf",
            "news_date": "2023-05-30 16:56:11",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference call with Analysts / Investors on Financial Results for the quarter and nine months ended 31st December, 2022",
            "news_id": "7d48e2a7-4c27-40dc-b775-ea2eb8b781c9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ad249fac-d0f8-498c-b333-bc4aff8d26fd.pdf",
            "news_date": "2023-02-01 17:49:29",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Conference Call With Analysts / Investors On Financial Results For The Quarter And Nine Months Ended 31St December, 2022",
            "news_body": "In continuation of our letter dated 12-Jan-23 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference call with Analysts / Investors on Financial Results of the Company for the quarter and nine months ended 31st December, 2022, has been placed on the Company's website athttps://www.torrentpharma.com/pdf/investors/Audio_Recording31122022.mp3",
            "news_id": "84eddf94-9646-46bd-89a7-d089cfc99e3e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea213b90-ed26-41cf-b8a1-967a9479479a.pdf",
            "news_date": "2023-01-25 19:54:35",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation to analysts on unaudited Consolidated Financial Results for the quarter and nine months ended 31st December, 2022",
            "news_id": "a402514f-38da-44c2-a298-a674c02a280e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fab33659-9711-4d55-b08e-080d5fad8e38.pdf",
            "news_date": "2023-01-25 17:13:30",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Submission / Intimation Under Regulation 30 Of The SEBI (Listing Obligations And<BR> Disclosure Requirements) Regulations, 2015 (Listing Regulations)",
            "news_body": "Submission / Intimation under Regulation 30 of the SEBI (Listing Obligations and<BR> Disclosure Requirements) Regulations, 2015 (Listing Regulations)",
            "news_id": "2edd93fa-0822-46ef-8805-c2f4efbc7dd0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4062f649-ed4b-4442-b458-dd793f15401d.pdf",
            "news_date": "2023-01-25 16:40:45",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission / Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')",
            "news_body": "Submission / Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')",
            "news_id": "9537556f-50cd-4ff0-b2d6-0f05aad7697c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5703c9fc-4087-4bb1-8d72-93c251e7435f.pdf",
            "news_date": "2023-01-25 16:37:37",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference call with Analysts / Investors on Financial Results for the quarter and half year ended 30th September, 2022",
            "news_id": "f750b26e-4bb2-4787-8bbf-be4c24b1b56f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bcb20c10-412e-4205-b6ab-be870f8cbcca.pdf",
            "news_date": "2022-10-28 19:26:21",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Conference Call With Analysts / Investors On Financial Results For The Quarter And Half Year Ended 30Th September, 2022",
            "news_body": "In continuation of our letter dated 14-Oct-22 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference call with Analysts / Investors on Financial Results of the Company for the quarter and half year ended 30th September, 2022, has been placed on the Company's website athttps://www.torrentpharma.com/pdf/investors/Audio_Recording30092022.mp3",
            "news_id": "bf23313b-ede1-4b03-96ad-0f68314f2b52",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d77f09e7-1e73-4bab-adef-7c7abb7cb1af.pdf",
            "news_date": "2022-10-21 20:28:11",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance As Per Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Compliance as per Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015",
            "news_id": "e71116b8-b2b3-47ff-9aa7-0da8551da54a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=60101817-3a91-46ad-801c-4badebfe7446.pdf",
            "news_date": "2022-10-21 20:18:37",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Submission / Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')",
            "news_body": "Submission / Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')",
            "news_id": "dd233317-06d3-4ad2-b41d-a340cbb25213",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ecd0a71e-d220-46f4-bc37-7a70b1162da2.pdf",
            "news_date": "2022-10-21 18:09:03",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation to analysts on unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2022",
            "news_id": "cc507872-8918-4164-affd-21aeab803abf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1a8eac7-2285-4a71-8ecc-8cf8e40089e0.pdf",
            "news_date": "2022-10-21 18:01:12",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission / Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')",
            "news_body": "Submission / Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')",
            "news_id": "20de75aa-751f-4ee0-8fe9-81f3bf8b7035",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a66c5c0-04d3-4c66-a60e-f5d5a76bf746.pdf",
            "news_date": "2022-10-21 17:56:13",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation to analysts on acquisition of Curatio Health Care (I) Private Limited",
            "news_id": "8ef9839f-21f0-480f-a876-77387229c598",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dee30566-673a-4d11-b4ec-c550be8ba1ba.pdf",
            "news_date": "2022-09-27 15:41:48",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June, 2022",
            "news_id": "769f1412-f65e-45aa-b761-4ecf39c79c3d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4823ab49-a818-4a1d-b1f8-7b862487672c.pdf",
            "news_date": "2022-08-05 17:45:04",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Conference Call With Analysts / Investors On Financial Results For The Quarter Ended 30Th June, 2022",
            "news_body": "In continuation of our letter dated 21-Jul-22 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference call with Analysts / Investors on Financial Results of the Company for the quarter ended 30th June, 2022, has been placed on the Company's website at https://www.torrentpharma.com/pdf/investors/Audio_Recording30062022.mp3",
            "news_id": "a9fc0db8-ae8b-4ea7-b637-8f8d7ccf7a95",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1807fcd1-7111-4e1e-a3b1-a2184d69b16a.pdf",
            "news_date": "2022-07-30 12:02:22",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation to analysts on unaudited Consolidated Financial Results for the quarter ended 30th June, 2022",
            "news_id": "43fc8928-2db0-476a-9c88-4c1ca9e0b22b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84e38bc3-c46b-4db8-90dc-393c08d50f53.pdf",
            "news_date": "2022-07-29 18:21:40",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Submission/ Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure<BR> Requirements) Regulations, 2015 (Listing Regulations)",
            "news_body": "Submission/ Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure<BR> Requirements) Regulations, 2015 (Listing Regulations)",
            "news_id": "854d3b08-7332-4dc1-9461-417a5f7b3485",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4bee4833-977d-41c3-a2f1-5392ccf959fe.pdf",
            "news_date": "2022-07-29 18:10:22",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission/ Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (Listing Regulations)",
            "news_body": "Submission/ Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations)",
            "news_id": "a81c35e0-0f26-45b6-bd3a-2b5a22b5bc03",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ed4c860-8472-4e2f-a474-179eb3981f59.pdf",
            "news_date": "2022-07-29 18:04:51",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference call with Analysts / Investors on Audited Financial Results for the quarter and year ended 31st March, 2022",
            "news_id": "5a95682c-3744-4e70-aafc-bf5035240b37",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52fae571-64dc-4b87-9201-bceb12fd6e59.pdf",
            "news_date": "2022-05-30 17:39:31",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Conference Call Wit''1 Analysts / Investors On Audited Financial Results For The Quarter And Year Ended 31St March, 2022",
            "news_body": "In continuation of our letter dated 20-May-22 and pm''suant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirem??nts) Regulations, 2015, the audio recording of Conference call with Analysts / Investors on Audited Financial Results of the Company for the quarter and year ended 31st March, 2022, has been placed on the Company''s website athttps://torrentpharma.com/pdf/investors/Audio_Recording31032022.mp3",
            "news_id": "0d4b2205-ba65-42d1-b6cd-1762486c97a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16496280-9561-4909-acee-eb231f7a67fe.pdf",
            "news_date": "2022-05-25 21:15:48",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance As .Per Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed the disclosure of Related Paity Transactions for the half year ended on 3 l-Mar-22",
            "news_id": "7596ea03-f7b5-4a41-9858-b44432672ee8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fd1c98d3-d409-45d2-b9d5-412cec5238c4.pdf",
            "news_date": "2022-05-25 19:07:24",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation to analysts on Audited Financial Results for the quarter and year ended 31st March, 2022",
            "news_id": "adec4c15-54ae-48c1-9dc0-45a94d7bfab0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e75a416-cb3c-4454-b5f5-2345af4e20d8.pdf",
            "news_date": "2022-05-25 18:12:52",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Disclosure Pursuant To Regulation 30 Read With Schedule III And Regulation 33 Of SEBI<BR> (Listing Obligations And Disclosure Requirements), 2015, (Listing Regulations)",
            "news_body": "Disclosure pursuant to Regulation 30 read with Schedule III and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015, (Listing Regulations)",
            "news_id": "c17f6b2e-4d17-4366-ba6a-56303e7209f8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1810a218-626b-453d-98be-aacf2927f257.pdf",
            "news_date": "2022-05-25 17:56:15",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Pursuant To Regulation 30 Read With Schedule III And Regulation 33 Of SEBI<BR> (Listing Obligations And Disclosure Requirements), 2015, (Listing Regulations)",
            "news_body": "Disclosure pursuant to Regulation 30 read with Schedule III and Regulation 33 of SEBI<BR> (Listing Obligations and Disclosure Requirements), 2015, (Listing Regulations)<BR>",
            "news_id": "fc93f364-75b4-4d23-8385-092ed807b690",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bac43a7b-86d0-4a95-b38c-10e0b5b2813b.pdf",
            "news_date": "2022-05-25 17:50:44",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "The presentation on unaudited Consolidated Financial Results for the quarter and nine months ended 31st December, 2021 to be made to analysts is enclosed for your records.",
            "news_id": "5cd97afe-085c-402d-a8d7-c45222d67391",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1a8b149-0395-4282-a0b9-65104500e795.pdf",
            "news_date": "2022-01-25 17:58:22",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission / Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, (''Listing Regulations'')",
            "news_body": "We would like to inform that the Board has at its meeting held today approved, inter-alia, the following:<BR> <BR> 1) Audited Standalone Financial Results along with audit report thereon and Unaudited Consolidated Financial Results along with the limited review report of the Company for the quarter and nine months ended on 31st December, 2021. The said financial results are enclosed herewith.<BR> <BR> In terms of Regulation 47 of the Listing Regulations, the Company will publish an extract of Unaudited Consolidated Financial Results for the quarter and nine months ended on                                            31st December, 2021. Both Standalone and Consolidated Financial Results will be available at Company's website www.torrentpharma.com.<BR> <BR> A Press Release on Financial Results which is being submitted to the media is also enclosed herewith.<BR> <BR> <BR>",
            "news_id": "b700dbd7-f9e5-4897-8087-9df96fe0fad1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5dc9b4c2-6a1b-44a0-81f0-aaa27392c1a8.pdf",
            "news_date": "2022-01-25 17:54:38",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance As Per Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed the Related Party Transactions on a consolidated basis for the half year ended on 30-Sep-21.<BR> <BR> Kindly take note of the above.<BR>",
            "news_id": "03ba65bd-252b-417a-adea-caecf08e7b38",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc000a06-2acd-4ff2-98d8-a33c59aa179d.pdf",
            "news_date": "2021-10-26 19:33:30",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "The presentation on unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2021 to be made to analysts is enclosed for your records.",
            "news_id": "b5952f02-51ea-4e72-be3a-af8c630daf35",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85110b94-5a79-4c4c-a51b-b066b99aa0e8.pdf",
            "news_date": "2021-10-26 18:09:25",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "The presentation on unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2021 to be made to analysts is enclosed for your records.",
            "news_id": "b6e8122c-ab1d-40bb-b533-cbe31c9ab227",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=553fc145-397f-4337-847b-a2e9fb206bbe.pdf",
            "news_date": "2021-10-26 18:00:26",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission / Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (''Listing Regulations'')",
            "news_body": "Outcome of Board Meeting dated 26-Oct-2021",
            "news_id": "02dffa13-d2e4-4226-bf2d-3933709a78a9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4e94c6b-d0d9-44af-9523-4db5332f606f.pdf",
            "news_date": "2021-10-26 17:48:58",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "The presentation on unaudited Consolidated Financial Results for the quarter ended 30th June, 2021 to be made to analysts is enclosed for your records.",
            "news_id": "dbdd2610-8bf1-44e6-9f9d-4b86c57e3104",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=187abfb1-dc45-4bea-bc47-9ec17cae457e.pdf",
            "news_date": "2021-07-27 17:28:33",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission / Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')",
            "news_body": "Outcome of Board Meeting dated 27-Jul-2021",
            "news_id": "b57179d4-4b7c-45ad-b827-0a81e1a7af46",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a403a56b-e7ab-4a3a-a977-3f70675f6ee0.pdf",
            "news_date": "2021-07-27 17:00:54",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance As Per Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed the Related Party Transactions on a consolidated basis for the half year ended on 31-Mar-21.<BR> <BR> Kindly take note of the above.",
            "news_id": "bce63021-6f89-40b9-9110-685bbebd84de",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2f45bc0-d0c9-41d1-96f7-9af95c99f8ab.pdf",
            "news_date": "2021-06-07 19:25:47",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation to analysts on Audited Financial Results for the quarter and year ended 31st March, 2021",
            "news_id": "6dea0689-3eac-46a5-bc08-72c4907284fa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2d38719-b67b-4956-99bd-aa47f6122573.pdf",
            "news_date": "2021-05-18 16:41:38",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Pursuant To Regulation 30 Read With Schedule III And Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Outcome of Board Meeting dated 18-May-2021.",
            "news_id": "9266b387-6ca1-431d-b3a8-5bcd848a519d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=912f1395-5fe5-4ca4-b3f9-8d273be2f838.pdf",
            "news_date": "2021-05-18 16:00:02",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}